Prospective Evaluation of Self-Testing to Increase Screening (PRESTIS)

NCT03898167 NA COMPLETED Results posted

Regularly attending for Pap test cervical cancer screening in a clinic is often unfeasible and/or unacceptable to many women. This study evaluates if mailing and testing self-sampled kits for high-risk human papillomavirus (HPV) can cost-effectively increase screening participation among underserved minority women in a safety-net health system.

Details

Lead sponsor	Baylor College of Medicine
Phase	NA
Status	COMPLETED
Enrolment	2474
Start date	Thu Feb 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Mon Mar 31 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Cervical Cancer
• Human Papillomavirus Infection

Interventions

• Telephone Recall
• Mailed HPV Self-Sampling Kit
• Patient Navigation

Countries

United States